Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study: The Lancet Neurology

for the FTD Prevention Initiative

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)145-156
Number of pages12
JournalLancet Neurol.
Volume19
Issue number2
DOIs
Publication statusPublished - 2020

Keywords

  • grn protein
  • guanine nucleotide exchange C9orf72
  • mapt protein
  • protein
  • unclassified drug
  • C9orf72 protein, human
  • GRN protein, human
  • MAPT protein, human
  • tau protein
  • adult
  • aged
  • Alzheimer disease
  • amyotrophic lateral sclerosis
  • Article
  • cohort analysis
  • death
  • disease duration
  • female
  • frontal variant frontotemporal dementia
  • frontotemporal dementia
  • gene mutation
  • genetic variability
  • human
  • male
  • onset age
  • parental age
  • parkinsonism
  • phenotype
  • primary progressive aphasia
  • priority journal
  • retrospective study
  • disease exacerbation
  • family
  • genetics
  • metabolism
  • middle aged
  • mortality
  • mutation
  • very elderly
  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • C9orf72 Protein
  • Cohort Studies
  • Disease Progression
  • Family
  • Female
  • Frontotemporal Dementia
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Phenotype
  • Progranulins
  • Retrospective Studies
  • tau Proteins

Cite this